Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	36.86	64.74	47.30
Graham Fair Price	38.62	24.29	17.52
PEG	-98.95	0.16	-15.45
Price/Book	1.81	2.67	2.63
Price/Cash Flow	34.30	213.50	158.98
Prices/Earnings	-44.34	14.33	25.75
Price/Sales	25.20	22.69	18.12
Price/FCF	34.30	213.50	158.98
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-7.44	0.59	0.64
Operating Margin	-9.18	0.35	0.39
ROA	84.87	0.01	< 0.005
ROE	0.03	0.05	82.92
ROIC	0.02	0.01	-24.75
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.09	< 0.005	5968.65
Dividends QOQ	< 0.005	0.10	4114.15
EBIT QOQ	0.45	-0.24	-45.80
EPS QOQ	-0.02	0.88	5188.14
FCF QOQ	-0.22	-0.22	-0.45
Revenue QOQ	-0.04	-0.17	-306.81
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	76.83	82.35	7.18
Days Sales Outstanding (DSO)	79.03	81.58	3.22
Inventory Turnover	1.17	1.09	-6.70
Debt/Capitalization	0.61	0.62	2.48
Quick Ratio	0.31	0.28	-11.71
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	23.13	23.71	2.50
Cash	1.31	0.80	-38.94
Capex	-1.02	-1.20	-17.89
Free Cash Flow	0.38	0.30	-22.30
Revenue	3.35	2.79	-16.66
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.55	0.51	-6.94
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	17.09	24.33	42.35
Naive Interpretation	Member

06 - Financial Health · Bad

Rating